ClinicalTrials.govpublic full text
Tarceva and Capecitabine for Pancreatic Cancer
pancreatic cancer, neoplasm metastasis, second line therapy, gemcitabine refractory, capecitabine, tarceva, osi-774, metastatic pancreatic cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 847064
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.